Schwab Andrew J.
SEC CIK 1598549 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | Dir, 10% | 0 | — | $3.00M | 8 | 2023-08-18 | 2026-09-22 |
| CAMP | Camp4 Therapeutics Corp | Dir, 10% | 2.03M | $10.00M | $2.50M | 6 | 2024-10-15 | 2026-08-27 |
| TRDA | Entrada Therapeutics, Inc. | 10% | 1.11M | $5.00M | $866.5K | 4 | 2021-11-02 | 2025-06-27 |
| ELVN | Enliven Therapeutics, Inc. | Dir | 4.47M | — | $7.04M | 2 | 2023-02-23 | 2023-08-24 |
| RLYB | Rallybio Corp | 10% | 2.38M | — | $820.0K | 1 | 2023-03-07 | 2023-03-07 |
| VOR | Vor Biopharma Inc. | 10% | 4.60M | — | $5.06M | 1 | 2021-11-16 | 2021-11-16 |
Most active insiders at SKYE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 5AM Partners VII, LLC | 10% | — | $444.6K |
| 2 | Schwab Andrew J. | Dir, 10% | — | $444.6K |
| 3 | DHILLON PUNIT | CEO, Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-24 16:31 | 2026-09-22+ | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $1.62 | -148.1K | 0 | -100% | -$239.6K |
| MI | 2026-09-18 18:39 | 2026-09-16 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $1.91 | -33.9K | 5,616 | -86% | -$64.7K |
| I | 2026-08-31 17:05 | 2026-08-27 | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir | S - Sale | $4.04 | -400.0K | 2.03M | -16% | -$1.62M |
| I | 2026-08-26 16:57 | 2026-08-24 | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir | S - Sale | $4.50 | -10 | 2.43M | -0.0% | -$45 |
| MI | 2026-08-21 16:59 | 2026-08-19+ | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir | S - Sale | $4.59 | -191.9K | 2.43M | -7% | -$879.7K |
| MI | 2026-08-20 17:59 | 2026-08-18+ | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $0.3733 | -375.8K | 7.85M | -5% | -$140.3K |
| I | 2025-09-15 | 2025-09-11 | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir, 10% | A - Grant | $1.53 | +2.94M | 2.94M | New | +$4.50M |
| MI | 2025-08-22 | 2025-08-21+ | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $3.46 | -231.4K | 64.0K | -78% | -$800.5K |
| MI | 2025-07-01 | 2025-06-27+ | TRDA | Entrada Therapeutics, Inc. | Schwab Andrew J. | 10% | S - Sale | $6.93 | -32.1K | 1.11M | -3% | -$222.6K |
| M | 2025-07-01 | 2025-06-27+ | TRDA | Entrada Therapeutics, Inc. | Schwab Andrew J. | 10% | S - Sale | $6.93 | -92.9K | 3.20M | -3% | -$643.9K |
| DMI | 2024-10-15 | 2024-10-15 | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir, 10% | C - Cnv Deriv | — | +2.02M | 1.34M | New | — |
| DI | 2024-10-15 | 2024-10-15 | CAMP | Camp4 Therapeutics Corp | Schwab Andrew J. | Dir, 10% | P - Purchase | $11.00 | +909.1K | 2.63M | +53% | +$10.00M |
| MI | 2024-09-13 | 2024-09-11+ | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | S - Sale | $6.57 | -266.3K | 66.4K | -80% | -$1.75M |
| I | 2024-03-15 | 2024-03-13 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | A - Grant | $10.00 | +450.0K | 8.39M | +6% | +$4.50M |
| I | 2024-02-02 | 2024-01-31 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | A - Grant | $2.31 | +5.21M | 7.94M | +190% | +$12.03M |
| MI | 2023-08-28 | 2023-08-24 | ELVN | Enliven Therapeutics, Inc. | Schwab Andrew J. | 10% | S - Sale | $16.00 | -440.0K | 4.47M | -9% | -$7.04M |
| DMI | 2023-08-22 | 2023-08-18 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Dir, 10% | A - Grant | $0.01 | +1.13B | 267.60M | New | +$11.31M |
| I | 2023-03-09 | 2023-03-07 | RLYB | Rallybio Corp | Schwab Andrew J. | 10% | S - Sale | $8.20 | -100.0K | 2.38M | -4% | -$820.0K |
| MI | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | Schwab Andrew J. | Dir | A - Grant | — | +5.80M | 960.4K | New | — |
| MI | 2021-11-18 | 2021-11-16 | VOR | Vor Biopharma Inc. | Schwab Andrew J. | 10% | S - Sale | $15.30 | -330.7K | 4.60M | -7% | -$5.06M |
| DMI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | Schwab Andrew J. | 10% | C - Cnv Deriv | — | +3.83M | 882.4K | New | — |
| DI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | Schwab Andrew J. | 10% | P - Purchase | $20.00 | +250.0K | 1.13M | +28% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations